First National Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,213
| Closed | -$220K | – | 322 |
|
|
2019
Q3 | $220K | Sell |
2,213
-1,295
| -37% | -$123K | 0.02% | 288 |
|
|
2019
Q2 | $324K | Sell |
3,508
-848
| -19% | -$80.5K | 0.03% | 259 |
|
|
2019
Q1 | $411K | Sell |
4,356
-203
| -4% | -$17.8K | 0.04% | 235 |
|
|
2018
Q4 | $292K | Sell |
4,559
-1,761
| -28% | -$130K | 0.03% | 260 |
|
|
2018
Q3 | $566K | Sell |
6,320
-1,119
| -15% | -$98.9K | 0.06% | 217 |
|
|
2018
Q2 | $590K | Sell |
7,439
-1,546
| -17% | -$128K | 0.07% | 212 |
|
|
2018
Q1 | $802K | Sell |
8,985
-1,653
| -16% | -$159K | 0.09% | 192 |
|
|
2017
Q4 | $1.11M | Sell |
10,638
-1,643
| -13% | -$185K | 0.12% | 168 |
|
|
2017
Q3 | $1.79M | Buy |
12,281
+1,345
| +12% | +$183K | 0.21% | 123 |
|
|
2017
Q2 | $1.42M | Buy |
10,936
+427
| +4% | +$52.3K | 0.17% | 139 |
|
|
2017
Q1 | $1.31M | Buy |
10,509
+1,484
| +16% | +$178K | 0.17% | 140 |
|
|
2016
Q4 | $1.04M | Sell |
9,025
-2,206
| -20% | -$246K | 0.15% | 154 |
|
|
2016
Q3 | $1.17M | Sell |
11,231
-3,980
| -26% | -$431K | 0.18% | 133 |
|
|
2016
Q2 | $1.5M | Sell |
15,211
-228
| -1% | -$23.6K | 0.23% | 118 |
|
|
2016
Q1 | $1.55M | Sell |
15,439
-2,098
| -12% | -$216K | 0.24% | 122 |
|
|
2015
Q4 | $2.1M | Buy |
17,537
+2,090
| +14% | +$242K | 0.33% | 90 |
|
|
2015
Q3 | $1.67M | Sell |
15,447
-1,781
| -10% | -$221K | 0.29% | 107 |
|
|
2015
Q2 | $1.99M | Buy |
17,228
+3,213
| +23% | +$367K | 0.32% | 96 |
|
|
2015
Q1 | $1.61M | Buy |
14,015
+4,004
| +40% | +$478K | 0.28% | 108 |
|
|
2014
Q4 | $1.12M | Buy |
10,011
+199
| +2% | +$21K | 0.2% | 127 |
|
|
2014
Q3 | $930K | Buy |
9,812
+1,516
| +18% | +$137K | 0.18% | 130 |
|
|
2014
Q2 | $713K | Sell |
8,296
-168
| -2% | -$12.8K | 0.14% | 144 |
|
|
2014
Q1 | $591K | Buy |
8,464
+212
| +3% | +$16.8K | 0.11% | 152 |
|
|
2013
Q4 | $697K | Sell |
8,252
-462
| -5% | -$36.6K | 0.13% | 139 |
|
|
2013
Q3 | $671K | Sell |
8,714
-680
| -7% | -$47.7K | 0.13% | 138 |
|
|
2013
Q2 | $550K | Buy |
+9,394
| New | +$565K | 0.11% | 153 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
First National Trust's CELG Position: Q4 2019 in Review
First National Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,213 shares — an estimated $220K sold.
First National Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.1M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- First National Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- First National Trust sold 2,213 Celgene Corp shares in Q4 2019, an estimated $220K.
- First National Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- First National Trust's Celgene Corp position peaked at $2.1M in Q4 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on First National Trust's 13F filing for Q4 2019, filed 4 Feb 2020.